ARTICLE | Company News
Solasia, Lee’s Pharmaceutical Holdings Ltd. deal
December 7, 2015 8:00 AM UTC
Solasia granted Lee’s exclusive rights to commercialize Sancuso granisetron patch to treat chemotherapy-induced nausea and vomiting (CINV) in China, excluding Hong Kong and Macau. Solasia retains rights to promote the transdermal serotonin (5-HT3) receptor antagonist in Beijing, Shanghai and Guangzhou. ...